Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

258.15
-4.7500-1.81%
Post-market: 258.390.2385+0.09%17:26 EDT
Volume:4.76M
Turnover:1.23B
Market Cap:456.25B
PE:72.93
High:262.50
Open:260.81
Low:257.25
Close:262.90
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.12
T/O Rate:0.27%
Dividend:6.83
Dividend Rate:2.65%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-76.87
PE(LYR):109.39

Loading ...

AbbVie (ABBV) Boey Approval Puts Its Growth Story And Valuation Back In Focus

Simply Wall St.
·
Jul 17

Abbvie’s Allergan Aesthetics Wins EU Approval for Boey Frown-line Treatment

Reuters
·
Jul 17

Abbvie - European Commission Approves Boey for Temporary Improvement of Glabellar Lines in Adults

THOMSON REUTERS
·
Jul 17

Regenxbio Tumbles on Deep-discounted $100 Mln Equity Offering

Reuters
·
Jul 17

7 Stocks that actually play defence: Jon Erlichman

Bloomberg
·
Jul 17

Why Healthcare Stocks Look Like a Haven in This Market

Dow Jones
·
Jul 17

Why Abbott Stock is Having Its Best Day in 24 Years

Dow Jones
·
Jul 16

AbbVie Inc Stock (ABBV) Moved Up by 3.32% on Jul 16: What Signal Does It Send?

TradingKey
·
Jul 16

Movement Alert|AbbVie Rises 3.01% in Regular Trading, Multiple Investment Banks Raise Price Targets

Market Focus
·
Jul 16

Arcutis Appoints Mirum CEO Chris Peetz to Board

Reuters
·
Jul 16

Therapeuticsmd Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 16

Rxsight Names Aziz Mottiwala CEO, Ron Kurtz to Become Chief Medical Officer

Reuters
·
Jul 16

Analysts Are Bullish on Top Healthcare Stocks: Fractyl Health, Inc. (GUTS), AbbVie (ABBV)

TIPRANKS
·
Jul 16

AbbVie’s Bimatoprost SR Extension Data: Why Long-Term Glaucoma Safety Matters for Investors

TIPRANKS
·
Jul 16

Abbvie is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 15

Citigroup Adjusts Price Target on AbbVie to $260 From $230, Maintains Neutral Rating

MT Newswires Live
·
Jul 15

Abbvie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Abbvie Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since March 2025

Dow Jones
·
Jul 14

Skinmedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development

THOMSON REUTERS
·
Jul 14

Therapeuticsmd Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14